Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
5.01%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 1.61Close
$ 1.27 - $ 5.1 52-Week Range
Ticker Information
Ticker
MXCTCompany Name
MAXCYTE INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQMAXCYTE INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MXCT - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1.79M | 5.01% | $ 35.75M |
| 3/31/2025 | $ 1.5M | 3.98% | $ 37.68M |
| 12/31/2024 | $ 1.65M | 4.27% | $ 38.63M |
| 9/30/2024 | $ 2.42M | 5.3% | $ 45.6M |
| 6/30/2024 | $ 2.73M | 6.01% | $ 45.44M |
| 3/31/2024 | $ 2.95M | 6.69% | $ 44.05M |
| 12/31/2023 | $ 3.69M | 8.94% | $ 41.29M |
| 9/30/2023 | $ 4.97M | 13.06% | $ 38.05M |
| 6/30/2023 | $ 7.73M | 19% | $ 40.69M |
| 3/31/2023 | $ 14.03M | 34% | $ 41.25M |
Key Performance Insights, Last 5 Years
- MAXCYTE INC's latest trailing twelve months (TTM) CapEx % stands at 7.92%.
- Over the past 5 years, MAXCYTE INC's average CapEx % has been 16.88%.
- The median CapEx % for MAXCYTE INC during this period was 10.12%
- MAXCYTE INC reached its highest CapEx % over the past 5 years at 41.75%.
- The lowest CapEx % recorded by MAXCYTE INC in the same timeframe 3.98%
MAXCYTE INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for MAXCYTE INC is calculated as follows: CapEx [ $ 2.07M ] / Revenues [ $ 26.17M ]
(=) CapEx % [ 7.92% ] MXCT - Capital Expenditures Margin, Last 5 years
3.98%
Minimum
Mar 31, 2025
41.75%
Maximum
Dec 31, 2022
16.88%
Average
10.12%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |